451 related articles for article (PubMed ID: 22836056)
1. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.
Voordeckers M; Farrag A; Everaert H; Tournel K; Storme G; Verellen D; De Ridder M
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):443-8. PubMed ID: 22836056
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer.
Voordeckers M; Everaert H; Tournel K; Verellen D; Baron I; Van Esch G; Vanhove C; Storme G
Strahlenther Onkol; 2008 Aug; 184(8):400-5. PubMed ID: 18956516
[TBL] [Abstract][Full Text] [Related]
3. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
4. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
7. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
8. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
[TBL] [Abstract][Full Text] [Related]
9. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland-sparing helical tomotherapy for head and neck cancer: Preserved salivary function on quantitative salivary gland scintigraphy after tomotherapy.
Kreps S; Berges O; Belin L; Zefkili S; Petras S; Giraud P
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Sep; 133(4):257-62. PubMed ID: 27291482
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of an image-guided versus a non-image-guided setup approach in terms of delivered dose to the parotid glands in head-and-neck cancer IMRT.
Duma MN; Kampfer S; Wilkens JJ; Schuster T; Molls M; Geinitz H
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1266-73. PubMed ID: 20350787
[TBL] [Abstract][Full Text] [Related]
13. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.
Eisbruch A; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Anzai Y; Marsh LH; Martel MK; Ten Haken RK; Wolf GT; Ship JA
Acta Otorhinolaryngol Belg; 1999; 53(3):271-5. PubMed ID: 10635407
[TBL] [Abstract][Full Text] [Related]
14. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
15. Geometric factors influencing dosimetric sparing of the parotid glands using IMRT.
Hunt MA; Jackson A; Narayana A; Lee N
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):296-304. PubMed ID: 16904529
[TBL] [Abstract][Full Text] [Related]
16. Sparing the parotid glands and surgically transferred submandibular gland with helical tomotherapy in post-operative radiation of head and neck cancer: a planning study.
Saibishkumar EP; Jha N; Scrimger RA; MacKenzie MA; Daly H; Field C; Fallone G; Parliament MB
Radiother Oncol; 2007 Oct; 85(1):98-104. PubMed ID: 17923162
[TBL] [Abstract][Full Text] [Related]
17. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer.
Bussels B; Maes A; Flamen P; Lambin P; Erven K; Hermans R; Nuyts S; Weltens C; Cecere S; Lesaffre E; Van den Bogaert W
Radiother Oncol; 2004 Dec; 73(3):297-306. PubMed ID: 15588874
[TBL] [Abstract][Full Text] [Related]
18. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.
Eisbruch A; Ten Haken RK; Kim HM; Marsh LH; Ship JA
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):577-87. PubMed ID: 10524409
[TBL] [Abstract][Full Text] [Related]
19. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism.
Roach MC; Turkington TG; Higgins KA; Hawk TC; Hoang JK; Brizel DM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):321-6. PubMed ID: 21030160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]